ADIPOGENIX AND UNIGEN ENTER JOINT AGREEMENT TO DISCOVER AND DEVELOP PLANT-BASED THERAPEUTICS THAT TARGET FAT

AdipoGenix Inc. and Unigen Pharmaceuticals, Inc. today announced that they have entered into an agreement for the joint discovery and development of natural products that target human fat. AdipoGenix is a biopharmaceutical company developing small molecule therapies for obesity, type 2 diabetes and associated morbidities, and Unigen is a leading natural products research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-06-2006/0004335399&EDATE=)